Enthlt kein Gluten, keine Milchprodukte, keine Erdnsse, keine Baumnsse, keinen Fisch, keine Krustentiere, kein Soja, kein Sesam, keine Eier, keine knstlichen Aromen, Farbstoffe, Sstoffe oder unntige Zusatzstoffe.
Outcomes and objectives The primary objective was to compare the efficacy of 68 weeks of subcutaneous semaglutide 2.4 mg weekly versus placebo administration, as an adjunct to diet and exercise, on %WL in participants with less than 20% weight loss after primary GB or SG at the end of 68 weeks of treatment
Doctronics AI-powered platform offers 24/7 access to licensed doctors who can evaluate your situation, discuss treatment options, and help navigate insurance coverage
Weight doesn't move